Limosilactobacillus fermentum HF06 ‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis
Journal of the Science of Food and Agriculture · 2024-02 · 104 (3) · 1702-1712
DOI: 10.1002/jsfa.13057 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of the Science of Food and Agriculture, online erschienen am 22.11.2023. Verfasst von Chunhong Liu und 8 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering and Chemistry, Harbin Institute of Technology, Harbin, China. Hauptthemen laut MEDLINE: Colitis, Ulcerative, Limosilactobacillus fermentum, Gastrointestinal Microbiome, Colitis. Die Arbeit wurde bisher 31-mal zitiert (Crossref) und nennt 66 Literaturangaben. Gefördert von: Natural Science Foundation of Sichuan Province.
Abstract (Originalsprache)
BACKGROUND Paraprobiotics and postbiotics have shown potential in the treatment of ulcerative colitis (UC). However, their in vivo application is still in its infancy and their mechanisms of action are not well understood. RESULTS Here, we investigated the mitigation effects of Limosilactobacillus fermentum HF06‐derived paraprobiotic (6‐PA) and postbiotic (6‐PS) on dextran sulfate sodium induced UC and the potential mechanisms. Results indicated that the administration of 6‐PA and 6‐PS resulted in the inhibition of weight loss and colon shortening in mice with UC. Furthermore, they led to a significant reduction in both fecal moisture content and the levels of proinflammatory cytokines and oxidative stress in the intestine of the mice. 6‐PA and 6‐PS treatment strengthened the intestinal mucosal barrier by dramatically upregulating the levels of zonula occludens‐1 and occludin proteins. In addition, 6‐PA and 6‐PS restored intestinal dysbiosis by regulating abundances of certain bacteria, such as Bifidobacterium , Faecalibaculum , Muribaculaceae, Corynebacterium , Escherichia‐Shigella and Clostridium_sensu_stricto_1 , and regulated the level of short‐chain fatty acids. CONCLUSION These findings illustrated for the first time that L. fermentum HF06‐derived paraprobiotic and postbiotic enhanced the intestinal barrier function, and restored gut microbiota alterations. © 2023 Society of Chemical Industry.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Chemical Engineering and Chemistry, Harbin Institute of Technology, Harbin, China.
- Dairy Nutrition and Function, Key Laboratory of Sichuan Province, New Hope Dairy Company Limited, Chengdu, China.
- Jiangsu HOWYOU Biotechnology Co. Ltd, Qidong, China.
ORCID-Profile: Chunhong Liu
Förderung
- Natural Science Foundation of Sichuan Province
Zitieren
APA
Liu, C., Qi, X., Li, D., Zhao, L., Li, Q., Mao, K., Shen, G., Ma, Y., & Wang, R. (2024). Limosilactobacillus fermentum HF06 ‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis. Journal of the Science of Food and Agriculture, 104(3), 1702-1712. https://doi.org/10.1002/jsfa.13057
Vancouver
Liu C, Qi X, Li D, Zhao L, Li Q, Mao K, et al. Limosilactobacillus fermentum HF06 ‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis. Journal of the Science of Food and Agriculture. 2024;104(3):1702-1712. doi:10.1002/jsfa.13057
BibTeX
@article{Liu2024,
author = {Liu, Chunhong and Qi, Xiaofen and Li, Dan and Zhao, Le and Li, Qiming and Mao, Kaidong and Shen, Guiqi and Ma, Ying and Wang, Rongchun},
title = {Limosilactobacillus fermentum HF06 ‐derived paraprobiotic and postbiotic alleviate intestinal barrier damage and gut microbiota disruption in mice with ulcerative colitis},
journal = {Journal of the Science of Food and Agriculture},
year = {2024},
volume = {104},
number = {3},
pages = {1702--1712},
doi = {10.1002/jsfa.13057}
}
EUVIMED